Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focus |
antibiotic drug discovery
|
| gptkbp:foundedYear |
2000
|
| gptkbp:founder |
gptkb:Thomas_Steitz
Karen S. Anderson William J. Weiss |
| gptkbp:headquartersLocation |
New Haven, Connecticut, United States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rib-X Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
cadazolid
delafloxacin |
| gptkbp:renamed |
gptkb:Melinta_Therapeutics
|
| gptkbp:website |
https://www.melinta.com/
|
| gptkbp:bfsParent |
gptkb:Melinta_Therapeutics
|
| gptkbp:bfsLayer |
7
|